Unither Pharmaceuticals
keyboard_backspaceBack to Home
Contact
3-5 rue Saint Georges
75009 Paris
France
Directeur commercial
About us
Unither Pharmaceuticals is a pharmaceutical subcontractor specializing in the development and manufacturing of liquid formulations (including eye drops, saline solutions, asthma medications in BFS single doses, and liquid stick-packs) for originator pharmaceutical companies and generic manufacturers. Currently employing more than 2,150 people in eight manufacturing plants in France, the United States, Brazil and China, Unither Pharmaceuticals has sales of €475 million in 2023.
For more information about the Unither Pharmaceuticals group, visit www.unither-pharma.com
Business offer
Recent innovations have opened up the possibility of using BFS technology to design aseptic packaging systems combining the efficiency of high-throughput production with the highest guarantees of sterility. The result is a new type of pre-filled, single-dose disposable device that can be produced in very large numbers with a high-speed rotary machine, at very competitive production costs. Euroject® can contribute to greater equity in access to new vaccines and to ensuring safe vaccine administration, while being simple and cost effective.
Activities
- Therapeutic Product
- Nervous Central System
- Infectiology
- Immunology
- Ophthalmology
- Inflammation
- Quality assurance, quality control & analytical process
- Batch release test
- Chemical, physical, biological test
- Quality control test support
- Post-production test
- Real-time stability test
- Formulation
- Formulation
- Dose
- Stability
- Excipients
- Adjuvants
- Sterilization
- Lyophilization
- Storage stability
- Delivery
- Route of Administration
- Devices associated
- Clinical trials
- Phase II
- Phase III
- Phase IV
- Regulatory filing
- Regulatory Filing
- Bioproduction/CMC/Analytical Quality Assessment, Quality Control
- Non-GMP pilot batch
- GMP batch
- CGMP
- Sterility
- Quality control
